Psychopharmacological studies on (--)-nuciferine and its Hofmann degradation product atherosperminine. 1978

S K Bhattacharya, and R Bose, and P Ghosh, and V J Tripathi, and A B Ray, and B Dasgupta

(--)-Nuciferine and its Hofmann degradation product atherosperminine showed divergent psychopharmacological effects. Because nuciferine has been reported to be a neuroleptic and atherosperminine has some chemical resemblance to dopamine, they were investigated for their dopamine-receptor activities. Nuciferine had a pharmacologic profile of action associated with dopamine-receptor blockade; i.e., it induced catalepsy, inhibited spontaneous motor activity, conditioned avoidance response, amphetamine toxicity and stereotypy. On the other hand, atherosperminine produced effects associated with dopamine receptor stimulation, i.e., stereotypy, increase in spontaneous motor activity and amphetamine toxicity, reversal of haloperidol-induced catalepsy and inhibition of conditioned avoidance response, inhibition of morphine analgesia, and potentiation of the anticonvulsant action of diphenylhydantoin. The results are discussed on the basis of the chemical configuration of the two compounds.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010616 Phenanthrenes POLYCYCLIC AROMATIC HYDROCARBONS composed of three fused BENZENE rings.
D002375 Catalepsy A condition characterized by inactivity, decreased responsiveness to stimuli, and a tendency to maintain an immobile posture. The limbs tend to remain in whatever position they are placed (waxy flexibility). Catalepsy may be associated with PSYCHOTIC DISORDERS (e.g., SCHIZOPHRENIA, CATATONIC), nervous system drug toxicity, and other conditions. Cerea Flexibilitas,Flexibility, Waxy,Anochlesia,Anochlesias,Catalepsies,Flexibilitas, Cerea,Flexibilities, Waxy,Waxy Flexibilities,Waxy Flexibility
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006591 Hexobarbital A barbiturate that is effective as a hypnotic and sedative. Evipan,Hexenal,Hexobarbitone,Sodium Hexobarbital,Hexobarbital, Sodium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine

Related Publications

S K Bhattacharya, and R Bose, and P Ghosh, and V J Tripathi, and A B Ray, and B Dasgupta
December 1966, Tetrahedron letters,
S K Bhattacharya, and R Bose, and P Ghosh, and V J Tripathi, and A B Ray, and B Dasgupta
January 1975, Journal of medicinal chemistry,
S K Bhattacharya, and R Bose, and P Ghosh, and V J Tripathi, and A B Ray, and B Dasgupta
December 1962, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
S K Bhattacharya, and R Bose, and P Ghosh, and V J Tripathi, and A B Ray, and B Dasgupta
December 1958, Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft,
S K Bhattacharya, and R Bose, and P Ghosh, and V J Tripathi, and A B Ray, and B Dasgupta
July 2011, Journal of pharmaceutical and biomedical analysis,
S K Bhattacharya, and R Bose, and P Ghosh, and V J Tripathi, and A B Ray, and B Dasgupta
July 1971, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
S K Bhattacharya, and R Bose, and P Ghosh, and V J Tripathi, and A B Ray, and B Dasgupta
January 1957, The Journal of nervous and mental disease,
S K Bhattacharya, and R Bose, and P Ghosh, and V J Tripathi, and A B Ray, and B Dasgupta
April 1976, Pharmacological research communications,
S K Bhattacharya, and R Bose, and P Ghosh, and V J Tripathi, and A B Ray, and B Dasgupta
June 1963, Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft,
S K Bhattacharya, and R Bose, and P Ghosh, and V J Tripathi, and A B Ray, and B Dasgupta
January 1954, Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft,
Copied contents to your clipboard!